Article Information
History
- September 11, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonathan C. M. Wan1,2,*,
- Katrin Heider1,2,*,
- Davina Gale1,2,
- Suzanne Murphy1,2,3,
- Eyal Fisher1,2,
- James Morris1,2,
- Florent Mouliere4,1,2,
- Dineika Chandrananda1,2,
- Andrea Marshall5,
- Andrew B. Gill3,
- Pui Ying Chan1,2,
- Emily Barker6,
- Gemma Young6,
- Wendy N. Cooper1,2,
- Irena Hudecova1,2,
- Francesco Marass1,2,#,
- Graham R. Bignell7,
- Constantine Alifrangis7,
- Mark R. Middleton8,
- Ferdia A. Gallagher3,
- Christine Parkinson3,
- Amer Durrani3,
- Ultan McDermott7,‡,
- Christopher G. Smith1,2,
- Charles Massie1,2,9,†,
- Pippa G. Corrie3,2,† and
- Nitzan Rosenfeld1,2,†,§
- 1Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK
- 2Cancer Research UK Major Centre – Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK
- 3Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
- 4Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam, The Netherlands
- 5Warwick Clinical Trials Unit, University of Warwick, Coventry, UK
- 6Cambridge Clinical Trials Unit – Cancer Theme, Cambridge, UK
- 7Wellcome Sanger Institute, Hinxton CB10 1SA, UK
- 8National Institute for Health Research Biomedical Research Centre, Oxford, UK
- 9Department of Oncology, University of Cambridge Hutchison–MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK
- #Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland
- ‡AstraZeneca, CRUK Cambridge Institute, Robinson Way, Cambridge, UK CB2 0RE
- ↵§Correspondence to: nitzan.rosenfeld{at}cruk.cam.ac.uk
↵* J.C.M.W. and K.H. contributed equally to this work